rs1553665500

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PM4

The ENST00000450420.6(MLH1):​c.1563A>C​(p.Ter521Cysext*?) variant causes a stop lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

MLH1
ENST00000450420.6 stop_lost

Scores

1
4
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 3.67

Publications

0 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Stoplost variant in ENST00000450420.6 Downstream stopcodon found after 530 codons.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000450420.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.2108A>Cp.Glu703Ala
missense
Exon 19 of 19NP_000240.1
MLH1
NM_001354628.2
c.2015A>Cp.Glu672Ala
missense
Exon 18 of 18NP_001341557.1
MLH1
NM_001354629.2
c.2009A>Cp.Glu670Ala
missense
Exon 18 of 18NP_001341558.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000450420.6
TSL:1
c.1563A>Cp.Ter521Cysext*?
stop_lost
Exon 14 of 14ENSP00000393006.2
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.2108A>Cp.Glu703Ala
missense
Exon 19 of 19ENSP00000231790.3
MLH1
ENST00000456676.7
TSL:1
c.1901A>Cp.Glu634Ala
missense
Exon 17 of 17ENSP00000416687.3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
1
-
Hereditary nonpolyposis colorectal neoplasms (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Benign
21
DANN
Benign
0.90
DEOGEN2
Uncertain
0.73
D
Eigen
Benign
-0.020
Eigen_PC
Benign
-0.051
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.0051
T
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.7
L
PhyloP100
3.7
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.45
Sift
Benign
0.33
T
Sift4G
Benign
0.41
T
Polyphen
0.0020
B
Vest4
0.14
MutPred
0.17
Loss of disorder (P = 0.096)
MVP
0.95
MPC
0.071
ClinPred
0.18
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.092
gMVP
0.47
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553665500; hg19: chr3-37091981; COSMIC: COSV51623426; COSMIC: COSV51623426; API